Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bevan

Showing results (721-730 of 3,443) with videos related to

Pageof 345
Sort By:
Clinical Pharmacology and Therapeutics|July 1, 1988
Cumulative dose-response with infusion: a technique to determine neuromuscular blocking potency of atracurium and vecuroniumC E Smith, F Donati, D R Bevan
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|August 1, 1997
Residual neuromuscular blockade after cardiac surgery: pancuronium vs rocuroniumL McEwin, P M Merrick, D R Bevan
The British Journal of Clinical Practice|January 1, 1992
Quinine-induced cutaneous vasculitisE J Price, J S Bevan, A Rees
Plos One|June 27, 2018
Agreement between pre-exercise screening questionnaires completed online versus face-to-faceLynda Norton, Jessica Thomas, Nadia Bevan, et al.
Clinical and Experimental Immunology|June 1, 1987
Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphologyV Malkovska, J Murphy, L Hudson, et al.
Clinical and Laboratory Haematology|August 10, 2000
Amiodarone-induced bone marrow granulomasN Y Boutros, S Dilly, D H Bevan
British Journal of Pharmacology|May 15, 2001
Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptorD Ramsay, N Bevan, S Rees, et al.
Current Cancer Drug Targets|November 11, 2008
Notch signaling: a potential therapeutic target in prostate cancerM A Villaronga, C L Bevan, B Belandia
Journal of Environmental Management|February 6, 2008
Environmental management of the stone cutting industryKhaled Nasserdine, Ziad Mimi, Blair Bevan, et al.
Immunity|July 1, 1996
Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3L L Lenz, B Dere, M J Bevan
Pageof 345

Showing results (721-730 of 3,443) with videos related to

Sort By:
Pageof 345
Clinical Pharmacology and Therapeutics|July 1, 1988
Cumulative dose-response with infusion: a technique to determine neuromuscular blocking potency of atracurium and vecuroniumC E Smith, F Donati, D R Bevan
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|August 1, 1997
Residual neuromuscular blockade after cardiac surgery: pancuronium vs rocuroniumL McEwin, P M Merrick, D R Bevan
The British Journal of Clinical Practice|January 1, 1992
Quinine-induced cutaneous vasculitisE J Price, J S Bevan, A Rees
Plos One|June 27, 2018
Agreement between pre-exercise screening questionnaires completed online versus face-to-faceLynda Norton, Jessica Thomas, Nadia Bevan, et al.
Clinical and Experimental Immunology|June 1, 1987
Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphologyV Malkovska, J Murphy, L Hudson, et al.
Clinical and Laboratory Haematology|August 10, 2000
Amiodarone-induced bone marrow granulomasN Y Boutros, S Dilly, D H Bevan
British Journal of Pharmacology|May 15, 2001
Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptorD Ramsay, N Bevan, S Rees, et al.
Current Cancer Drug Targets|November 11, 2008
Notch signaling: a potential therapeutic target in prostate cancerM A Villaronga, C L Bevan, B Belandia
Journal of Environmental Management|February 6, 2008
Environmental management of the stone cutting industryKhaled Nasserdine, Ziad Mimi, Blair Bevan, et al.
Immunity|July 1, 1996
Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3L L Lenz, B Dere, M J Bevan
Pageof 345